Schedule a Call

Blog

The Patient Journey: Discovery, Experience, and Attitudes Towards GLP-1 RAs and SGLT-2 Inhibitors Treatment

Maria Muccioli, PhD

Maria Muccioli, PhD

Research Director

Research Reports

We've tapped into our patient database, comprising over 65,000 individuals living with diabetes, to understand how GLP-1 RAs and SGLT-2 Inhibitors are impacting patients weight loss, their sentiment towards the pharmaceutical companies making the treatments, and the correlation between cost and adherence.

What you get

This report includes insights from:

  • 1,500+ US adults with type 2 diabetes

  • 40% non-white participants

  • 50% male / 50% female respondents 

About the author

Maria Muccioli, PhD

Maria Muccioli, PhD

Research Director

Maria brings clinical research expertise to her work overseeing healthcare market research programs for Thrivable customers. She earned a PhD in Molecular and Cellular Biology from Ohio University and was also a postdoctoral researcher at the Ohio State University and a fellow at the Brigham and Women’s Hospital and Harvard Medical School.

people illustration 15
Who do you want to connect with?
people illustration 13